Parra-Plaza, A.; Ugarte, A.; Benavent, E.; GarcÃa-Poutón, N.; Mujal, A.; Oltra, M.R.; Parra-Rojas, A.; Rico, V.; del RÃo, M.; Nicolás, D.
Use of Cefiderocol for Carbapenem-Resistant Gram-Negative Infections in Hospital at Home: Multicentric Real-World Experience. Antibiotics 2025, 14, 1216.
https://doi.org/10.3390/antibiotics14121216
AMA Style
Parra-Plaza A, Ugarte A, Benavent E, GarcÃa-Poutón N, Mujal A, Oltra MR, Parra-Rojas A, Rico V, del RÃo M, Nicolás D.
Use of Cefiderocol for Carbapenem-Resistant Gram-Negative Infections in Hospital at Home: Multicentric Real-World Experience. Antibiotics. 2025; 14(12):1216.
https://doi.org/10.3390/antibiotics14121216
Chicago/Turabian Style
Parra-Plaza, Andrea, Ainoa Ugarte, Eva Benavent, Nicole GarcÃa-Poutón, Abel Mujal, MarÃa Rosa Oltra, Andrés Parra-Rojas, Verónica Rico, Manuel del RÃo, and David Nicolás.
2025. "Use of Cefiderocol for Carbapenem-Resistant Gram-Negative Infections in Hospital at Home: Multicentric Real-World Experience" Antibiotics 14, no. 12: 1216.
https://doi.org/10.3390/antibiotics14121216
APA Style
Parra-Plaza, A., Ugarte, A., Benavent, E., GarcÃa-Poutón, N., Mujal, A., Oltra, M. R., Parra-Rojas, A., Rico, V., del RÃo, M., & Nicolás, D.
(2025). Use of Cefiderocol for Carbapenem-Resistant Gram-Negative Infections in Hospital at Home: Multicentric Real-World Experience. Antibiotics, 14(12), 1216.
https://doi.org/10.3390/antibiotics14121216
